Both C-DCE and HR-DCE parameters were not statistically associated with pathologic results, such as Ki-67 values and O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation status (p > 0.05), in patients with GBM (Supplementary Table 1). This evidence concerns the gene MKI67 and glioblastoma.